Recent advances in structural modification and biological activities of isoliquiritigenin and liquiritigenin.
- 1Department of Pharmacy, General Hospital, Ningxia Medical University Yinchuan 750004 China [email protected].
- 2School of Pharmacy, Ningxia Medical University Yinchuan 750004 China [email protected].
Abstract
Liquiritigenin and isoliquiritigenin, major bioactive flavonoids from licorice, exhibit promising pharmacological properties. However, their poor solubility, low oral bioavailability and weak metabolic stability limit their clinical application. Various site-specific structural modification strategies have been adopted by researchers to tackle these limitations. Functionalization with Mannich bases, prenyloxy groups, thiosemicarbazone moieties, halogens and glycosyl groups, as well as structural modifications via phosphorylation and acylation, can effectively tune their physicochemical properties, bioactivity, targeting ability and safety. These strategies support the rational design of potent flavonoid-derived drug candidates for clinical application.
Related
- Lycium ruthenicum as a Functional Food Resource: Chemical Composition, Nutritional Value, Health Benefits, and Biological Activities
- Isoliquiritigenin inhibits TGF-β1-induced epithelial–mesenchymal transition in pulmonary fibrosis by promoting Nix-mediated mitophagy
- Valorization of Pistacia vera By‐Products: Monthly Variation of Bioactive Compounds and Biological Activities
- Optimization of rosmarinic acid extraction from Thunbergia laurifolia leaves using a green solvent and evaluation of its biological activities
- Metabolite profiling and in vitro biological activities of an endophytic Cladosporium sp. AUMC 15471 isolated from Origanum syriacum L
BibTeX
@article{he2026recent,
title = {{Recent advances in structural modification and biological activities of isoliquiritigenin and liquiritigenin.}},
author = {Shaolong He and Chen Du and Junmei Liu and Shijie Wei and Zhizhong Wang},
journal = {RSC advances},
year = {2026},
month = oct,
doi = {10.1039/d6ra05533h},
url = {https://europepmc.org/article/MED/42899194},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Recent advances in structural modification and biological activities of isoliquiritigenin and liquiritigenin.
AU - Shaolong He
AU - Chen Du
AU - Junmei Liu
AU - Shijie Wei
AU - Zhizhong Wang
PY - 2026
DA - 2026/10/19
JO - RSC advances
DO - 10.1039/d6ra05533h
UR - https://europepmc.org/article/MED/42899194
AB - Liquiritigenin and isoliquiritigenin, major bioactive flavonoids from licorice, exhibit promising pharmacological properties. However, their poor solubility, low oral bioavailability and weak metabolic stability limit their clinical application. Various site-specific structural modification strategies have been adopted by researchers to tackle these limitations. Functionalization with Mannich bases, prenyloxy groups, thiosemicarbazone moieties, halogens and glycosyl groups, as well as structural modifications via phosphorylation and acylation, can effectively tune their physicochemical properties, bioactivity, targeting ability and safety. These strategies support the rational design of potent flavonoid-derived drug candidates for clinical application.
SN - 2046-2069
ER -